Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 7/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | BACE1 | P56817 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.81 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.62 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.62 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentosalen SCHEMBL29565922 | 0.90 | CYP3A4 (1.00) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| Pentosalen SCHEMBL50437 | 0.90 | CYP3A4 (1.00) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| Pentosalen SCHEMBL6267069 | 0.89 | CYP3A4 (0.98) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| Z-Trichoclin SCHEMBL19004128 | 0.87 | CYP3A4 (0.80) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| Collinin SCHEMBL29365336 | 0.78 | ALOX15 (0.72) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| SCHEMBL24994560 | 0.77 | CYP3A4 (0.65) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| SCHEMBL19346055 | 0.77 | CYP3A4 (0.65) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| SCHEMBL19331313 | 0.77 | CYP3A4 (0.65) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| SCHEMBL19345987 | 0.77 | CYP3A4 (0.65) | CYP3A4ALOX15TDP1BACE1KDM4E | |
| SCHEMBL31232680 | 0.77 | CYP3A4 (0.65) | CYP3A4ALOX15TDP1BACE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015882-A1 | Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-01-21 | — | — | US | claimed |
| US-10821148-B2 | Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-11-03 | — | — | US | claimed |
| US-20170258865-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS AND METHOD FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-09-14 | — | — | US | claimed |
| CN-120392743-A | Application of coumarin compound in preparation of procoagulant medicine | 云南中医药大学 | 2025-08-01 | — | — | CN | disclosed |
| US-12371633-B2 | Cold treatment | SYMRISE AG (DE) | 2025-07-29 | — | — | US | disclosed |
| CN-118403049-A | Application of notopterol and analogues thereof in preparation of coronavirus 3CL protease inhibitor | 陕西科技大学 | 2024-07-30 | — | — | CN | disclosed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-114166961-B | Method for measuring phenolic compounds in citrus juice product and pretreatment method thereof | 西南大学 | 2022-11-22 | — | — | CN | disclosed |
| CN-106994145-B | Pharmaceutical composition for treating or alleviating autoimmune diseases, complications thereof and/or nephritis and use of active ingredient thereof | 财团法人工业技术研究院 | 2022-05-03 | — | — | CN | disclosed |
| US-20210122995-A1 | COLD TREATMENT | SYMRISE AG (DE) | 2021-04-29 | — | — | US | disclosed |
| US-20210015882-A1 | Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-01-21 | — | — | US | disclosed |
| WO-2019024983-A1 | COLD TREATMENT | SYMRISE AG (DE) | 2019-02-07 | — | — | WO | disclosed |
| US-20170258865-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS AND METHOD FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-09-14 | — | — | US | disclosed |
| US-20170258865-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS AND METHOD FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-09-14 | — | — | US | disclosed |
| CN-106994145-A | Pharmaceutical composition for treating or alleviating autoimmune diseases, complications thereof and/or nephritis and use of active ingredient thereof | 财团法人工业技术研究院 | 2017-08-01 | — | — | CN | disclosed |
| US-20140349969-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | AKRON MOLECULES AG (AT) | 2014-11-27 | — | — | US | disclosed |
| EP-2674161-A1 | FMO3 inhibitors for treating pain | Akron Molecules GmbH (AT) | 2013-12-18 | — | — | EP | disclosed |
| US-20130252924-A1 | Compounds and Methods for Treating Pain | AKRON MOLECULES GMBH (AT) | 2013-09-26 | — | — | US | disclosed |
| EP-2637649-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | Akron Molecules GmbH (AT) | 2013-09-18 | — | — | EP | disclosed |
| WO-2012062925-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | AKRON MOLECULES GMBH (AT) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140349969-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | TRPV1, ACHE, OPRL1 | CYP3A4 2764/4885ALOX15 207/4885TDP1 3182/4885 |
| US-20170258865-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS AND METHOD FOR TREATING OR ALLEVIATING AN AUTOIMMUNE DISEASE AND/OR COMPLICATION THEREOF AND/OR NEPHRITIS | SSB, REN, RORC | CYP3A4 3336/4885ALOX15 826/4885TDP1 4642/4885 |
| US-20130252924-A1 | Compounds and Methods for Treating Pain | TRPV1, ACHE, OPRL1 | CYP3A4 2764/4885ALOX15 207/4885TDP1 3182/4885 |
| US-10821148-B2 | Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis | SSB, REN, RORC | CYP3A4 3336/4885ALOX15 826/4885TDP1 4642/4885 |
| US-20210015882-A1 | Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis | SSB, REN, RORC | CYP3A4 3336/4885ALOX15 826/4885TDP1 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.